Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MM

Mwangi W. Mutahi — 15 Patents

SCSchering: 13 patents #214 of 2,442Top 9%
PDPharmacopeia Drug Discovery: 1 patents #108 of 193Top 60%
Merck: 1 patents #5,440 of 9,382Top 60%
SPSchering-Plough Healthcare Products: 1 patents #190 of 322Top 60%
Edison, NJ: #116 of 1,355 inventorsTop 9%
New Jersey: #5,772 of 69,400 inventorsTop 9%
Overall (All Time): #307,048 of 4,157,543Top 8%
15 Patents All Time
Mwangi W. Mutahi has been granted 15 US patents while listed as an inventor at Schering. The first was granted in 2003 and the most recent in February 2013. Mwangi W. Mutahi ranks #307,048 of 4,157,543 US inventors in our database (top 7.4%). Patent records list Mwangi W. Mutahi in Edison, NJ, US.

Patents per Year

Patents granted per year, 2003 to 2013Bar chart with a peak of 3 patents in 2007.peak 32003: 1 patents20032004: 2 patents20042005: 2 patents20052006: 1 patents20062007: 3 patents20072008: 1 patents20082009: 2 patents20092010: 1 patents20102011: 1 patents20112013: 1 patents2013

Issued Patents All Time

Showing 1–15 of 15 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
8383818 Functionally selective alpha2C adrenoreceptor agonists Junying Zheng, Jianhua Chao, Kevin D. McCormick, Robert G. Aslanian, Christopher W. Boyce +1 more 2013-02-26 $57,688,000
7879880 Substituted aniline derivatives useful as histamine H3 antagonists Daniel M. Solomon, Robert G. Aslanian, Michael Y. Berlin, Manuel de Lera Ruiz, Kevin D. McCormick +1 more 2011-02-01
7846946 Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists Robert G. Aslanian, Michael Y. Berlin, Christopher W. Boyce, Jianhua Chao, Manuel de Lera Ruiz +9 more 2010-12-07
7638531 Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists Robert G. Aslanian, Michael Y. Berlin, Christopher W. Boyce, Manuel de Lera Ruiz, Kevin D. McCormick +7 more 2009-12-29
7635705 Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists Robert G. Aslanian, Michael Y. Berlin, Christopher W. Boyce, Jianhua Chao, Manuel de Lera Ruiz +9 more 2009-12-22
7408066 Carbon-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists Robert G. Aslanian, Michael Y. Berlin, Ying Huang, Kevin D. McCormick, Neng-Yang Shih +3 more 2008-08-05 $376,228,000
7300941 Non-imidazole compounds Robert G. Aslanian, Neng-Yang Shih, Pauline C. Ting, Michael Y. Berlin, Stuart B. Rosenblum +5 more 2007-11-27 $287,299,000
7238688 Piperidine compounds Stuart B. Rosenblum, Qingbei Zeng, Robert G. Aslanian, Pauline C. Ting, Neng-Yang Shih +6 more 2007-07-03 $194,740,000
7220735 Benzimidazolone histamine H3 antagonists Pauline C. Ting, Robert G. Aslanian, Michael Y. Berlin, Christopher W. Boyce, Jianhua Cao +7 more 2007-05-22 $108,242,000
7105505 Benzimidazole derivatives useful as histamine H3 antagonists Qingbei Zeng, Robert G. Aslanian, Michael Y. Berlin, Christopher W. Boyce, Jianhua Cao +7 more 2006-09-12 $71,279,000
6951871 Indole derivatives useful as histamine H3 antagonists Robert G. Aslanian, Michael Y. Berlin, Pietro Mangiaracina, Kevin D. McCormick, Stuart B. Rosenblum 2005-10-04 $159,976,000
6849621 Piperidine compounds Stuart B. Rosenblum, Qingbei Zeng, Robert G. Aslanian, Pauline C. Ting, Neng-Yang Shih +6 more 2005-02-01
6762186 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists Neng-Yang Shih, Robert G. Aslanian, Daniel M. Solomon, Stuart B. Rosenblum, Tom G. Wing +3 more 2004-07-13 $81,915,000
6720328 Non-imidazole compounds Robert G. Aslanian, Neng-Yang Shih, Pauline C. Ting, Michael Y. Berlin, Stuart B. Rosenblum +5 more 2004-04-13 $84,372,000
6518287 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists Robert G. Aslanian, Stuart B. Rosenblum, Neng-Yang Shih, John J. Piwinski 2003-02-11 $128,123,000